Prelude Therapeutics IncorporatedPRLD 
$2.47-5.00%24h
-5.00%24h
Global rank21050
Market cap$103.69M
Change 7d-11.15%
YTD Performance-42.15%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings-$121.83M
Dividend yield-
Main Sector
Healthcare
Prelude Therapeutics Incorporated Revenue data
According to Prelude Therapeutics Incorporated latest financial reports the company had revenue of $0 in 2023-12-31, a NaN% decrease from 2022. Prelude Therapeutics Incorporated highest revenue was $0 in 2023.
Revenue history for Prelude Therapeutics Incorporated from 2020 to 2024
-
Value:-
Prelude Therapeutics Incorporated revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $0 | NaN% |
| 2022 | $0 | NaN% |
| 2021 | $0 | NaN% |
| 2020 | $0 | - |
View the top revenue stocks 
